Pharmaceutical Technology
MARCH 8, 2023
Eli Lilly has announced that it will reduce the price of its most commonly used insulin, Humalog, in the US, by 70% and cap the out-of-pocket cost for those on commercial insurance at $35. This follows on from recent US federal action, the Inflation Reduction Act, that legislated reducing the Medicare beneficiary insulin out-of-pocket costs at $35 a month.
Bio Pharma Dive
MARCH 8, 2023
The decision by Covis Pharma closes a yearslong battle over continued use of Makena, the only treatment available for prevention of early labor.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MARCH 8, 2023
The US Food and Drug Administration (FDA) has granted approval for Shorla Oncology’s Nelarabine Injection, an oncology drug, to treat T-cell leukaemia, an aggressive blood and bone marrow cancer that progresses quickly. The oncology drug has been approved to treat T-cell Lymphoblastic Lymphoma (T-LBL) and T-cell Acute Lymphoblastic Leukemia (T-ALL).
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 8, 2023
To transform reality into the mental landscape that occupies out minds, our brain performs a multitude of operations. Some are short-cuts; assumptions that become obvious the moment we attempt to make sense of the conflict presented in an optical illusion.
Pharmaceutical Technology
MARCH 8, 2023
Global science and technology innovator Danaher has entered a strategic collaboration with the University of Pennsylvania for cellular immunotherapies to address manufacturing challenges impacting cell therapy uptake. The multi-year collaboration aims to develop new technologies which will help in improving clinical outcomes for patients. The new technologies will also overcome the manufacturing bottlenecks in delivering advanced engineered cell products.
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 8, 2023
Computational chemistry is today very much required for pharmaceutical compliance including prediction of toxic behaviour of nitrosamine for drug safety, according to experts. Identification and determination of toxic behaviour of a molecule is one of the most difficult challenges faced in ensuring drug safety.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Medical Xpress
MARCH 8, 2023
Exposure to low doses of ionizing radiation is associated with a modestly increased excess risk of heart disease, finds an analysis of the latest evidence published by The BMJ today.
NPR Health - Shots
MARCH 8, 2023
Researchers used data from more than 150 countries to connect gender equality and life expectancy. They hope their findings can help policymakers set priorities in public health and other areas.
Medical Xpress
MARCH 8, 2023
A common method of detecting prostate cancer may not be accurate enough as a reliable screening tool by itself, scientists have warned.
NPR Health - Shots
MARCH 8, 2023
The FDA posted recall notices for certain eyedrops distributed by Pharmedica and Apotex, including an over-the-counter product, Purely Soothing 15% MSM Drops, "that could result in blindness.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Medical Xpress
MARCH 8, 2023
The omicron variant of SARS-CoV-2 is much less likely to lead to long COVID than the variant circulating at the start of the COVID-19 pandemic, new research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen, April 15-18) suggests.
NPR Health - Shots
MARCH 8, 2023
Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.
Medical Xpress
MARCH 8, 2023
Spinal cord stimulation, a medical technology suggested to treat people with chronic back pain, does not provide long-term relief and may cause harm, according to a Cochrane Review released today.
STAT News
MARCH 8, 2023
Teletherapy has made mental health care more accessible than ever before, making care possible for people who otherwise would never have been able to get it. But the antiquated system of licensure in the United States is creating a huge barrier to realizing the potential for telehealth. I’ve seen the benefits of teletherapy firsthand. As the founder and CEO of Alma, a mental health company that helps independent mental health providers run their private practice and accept insurance, we s
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Medical Xpress
MARCH 8, 2023
According to a research letter published in JAMA Internal Medicine, prostate cancer screening frequently results in biopsies that find clinically insignificant cancer or no cancer at all.
NPR Health - Shots
MARCH 8, 2023
Before the pandemic halted travel, some 1.2 million American citizens visited Mexico for health care. The number is rising quickly again, with border restrictions eased.
Medical Xpress
MARCH 8, 2023
Breast cancer undisputedly has the highest incidence rate in female patients. Moreover, out of the six major cancers, it is the only one that has shown an increasing trend over the past 20 years.
STAT News
MARCH 8, 2023
Last week, the Food and Drug Administration issued an emergency authorization for the first at-home Covid-19 and flu combination test. The news came just days after the test’s maker, Lucira, filed for bankruptcy, blaming the FDA’s “protracted” approval process for its financial problems. Now the FDA has released a rare comment clarifying what happened during its authorization process.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Medical Xpress
MARCH 8, 2023
Elevated blood pressure and hypertension can cause early cardiac damage during adolescence which is worsened by young adulthood, a paper published in the Journal of Pediatrics concludes. The study was conducted in collaboration between the University of Bristol in the U.K. and the University of Eastern Finland.
STAT News
MARCH 8, 2023
Gastroenterologist Alin Botoman had been on hold for almost an hour. The drone of muzak taunted him on speaker phone. It was the second day in a row he’d spent trying to get insurance to cover a dual CT/PET scan he’d already performed for his patient with esophageal cancer. The day before, after the insurance company unexpectedly denied the request, he’d called to contest the decision and spent an hour on hold.
Medical Xpress
MARCH 8, 2023
Before new therapies can reach patients, they must be tested in clinical trials in representative populations to show that they work and are safe. Failure to enroll enough participants in trials can delay the arrival of new therapies in the clinic and inflate their eventual price tags. Failure to recruit diverse patients could diminish the relevance and generalizability of trial findings.
STAT News
MARCH 8, 2023
WASHINGTON — A federal proposal to impose new restrictions on a key addiction-treatment medication has caused an uproar in certain segments of the medical community. But health secretary Xavier Becerra seems to be on board. The new Drug Enforcement Administration proposal would require that patients receive an in-person examination before obtaining refills of buprenorphine , a key drug used to treat opioid use disorder.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Medical Xpress
MARCH 8, 2023
The most common type of brain cyst (arachnoid) has no known cause. New research investigating patients with these cysts has found something unexpected—a potential genetic link.
STAT News
MARCH 8, 2023
“Living With” explores the contours of life with chronic illness, from the prelude to diagnosis to new patterns of living, to wrestling with big questions about illness and health. In 2020, Sandra Coplin, now 66, moved her life from her native New York — at the time, an epicenter of Covid’s devastation — to North Haven, Conn., to be close to family.
Medical Xpress
MARCH 8, 2023
Over the past 20 years, the death rate from drug poisonings in the U.S. has tripled and suicide and alcoholic liver disease death rates have increased by 30%—particularly among middle-aged white Americans, according to studies by the National Center for Health Statistics.
Outsourcing Pharma
MARCH 8, 2023
The two partners will pool capabilities to provide an expanded service to their clients, which will see Koneksa provide its digital biomarkers tools and SSI Strategy its expertise in drug development.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Medical Xpress
MARCH 8, 2023
COVID-19 has taken a relatively limited toll on the mental health of most people around the globe, according to a paper published today in The BMJ by a McGill University-led research team involving collaborators from McMaster University, the University of Toronto, and other institutions.
STAT News
MARCH 8, 2023
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is caramel apple, a sweet treat.
Medical Xpress
MARCH 8, 2023
The research group led by Prof. Zeng Zhutian from the Division of Life Sciences and Medicine of the University of Science and Technology of China (USTC) revealed a new mechanism of immune surveillance by liver-resident macrophages called Kupffer cells (KCs) that prevent liver metastasis from occurring. They also developed a new method for in situ targeted expression and remodeling of KCs' anti-tumor function, which successfully cleared tumors in various animal models with end-stage liver metasta
STAT News
MARCH 8, 2023
WASHINGTON — Medicare officials are still hammering out the technical specifics of how the massive program will start to negotiate drug prices — let alone the substantive ones, Medicare chief Meena Seshamani said at a STAT event Tuesday. “There are operations that need to be stood up both on the [Medicare] side and on the manufacturer side,” she said, describing “monthly technical calls.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
264 
Let's personalize your content